RT Journal Article
SR Electronic
T1 604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A687
OP A687
DO 10.1136/jitc-2023-SITC2023.0604
VO 11
IS Suppl 1
A1 Marrone, Kristen A
A1 Landon, Blair V
A1 Topper, Michael J
A1 Tsai, Hua-Ling
A1 Balan, Archana
A1 Niknafs, Noushin
A1 Cherry, Christopher
A1 White, James
A1 Hu, Chen
A1 Riemer, Joanne
A1 Fitzpatrick, Margaret
A1 Forde, Patrick
A1 Hann, Christine
A1 Kelly, Ronan
A1 Ettinger, David
A1 Levy, Benjamin
A1 Nieva, Jorge
A1 Herman, James
A1 Velculescu, Victor
A1 Anagnostou, Valsamo
A1 Baylin, Stephen
A1 Brahmer, Julie
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A687.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.